Compile Data Set for Download or QSAR
Report error Found 125 Enz. Inhib. hit(s) with all data for entry = 1907
TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329882BDBM329882(US9663525, Compound I-090 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329883BDBM329883(US9663525, Compound I-091 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329886BDBM329886(US9663525, Compound I-094 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329884BDBM329884(US9663525, Compound I-092 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329885BDBM329885(US9663525, Compound I-093 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329874BDBM329874(US9663525, Compound I-082 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329875BDBM329875(US9663525, Compound I-083 | (rac)-[(1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329873BDBM329873(US9663525, Compound I-081 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329878BDBM329878(US9663525, Compound I-086 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329879BDBM329879(US9663525, Compound I-087 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329876BDBM329876(US9663525, Compound I-084 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329877BDBM329877(US9663525, Compound I-085 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329898BDBM329898(US9663525, Compound I-106 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329899BDBM329899(US9663525, Compound I-107 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329896BDBM329896(US9663525, Compound I-104 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329889BDBM329889(US9663525, Compound I-097 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329902BDBM329902(US9663525, Compound I-110 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329903BDBM329903(US9663525, Compound I-111 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329900BDBM329900(US9663525, Compound I-108 | (s.e.)-[(1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329901BDBM329901(US9663525, Compound I-109 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329794BDBM329794(US9663525, Compound I-002 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329891BDBM329891(US9663525, Compound I-099 | (rac)-rel-5-[7-({(1R,2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329888BDBM329888(US9663525, Compound I-096 | (rac)-methyl rel-5-[7-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329889BDBM329889(US9663525, Compound I-097 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329858BDBM329858(US9663525, Compound I-066 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329802BDBM329802(US9663525, Compound I-010 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329892BDBM329892(US9663525, Compound I-100 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329836BDBM329836(US9663525, Compound I-044 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329914BDBM329914(US9663525, Compound I-122 | (rac)-[(1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329915BDBM329915(US9663525, Compound I-123 | (rac)-{(1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329912BDBM329912(US9663525, Compound I-120 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329913BDBM329913(US9663525, Compound I-121 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329906BDBM329906(US9663525, Compound I-114 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329907BDBM329907(US9663525, Compound I-115 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329904BDBM329904(US9663525, Compound I-112 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329905BDBM329905(US9663525, Compound I-113 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329910BDBM329910(US9663525, Compound I-118 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329911BDBM329911(US9663525, Compound I-119 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329908BDBM329908(US9663525, Compound I-116 | (s.e.)-((1R,2R,3S,4R)-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329802BDBM329802(US9663525, Compound I-010 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329807BDBM329807(US9663525, Compound I-015 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329794BDBM329794(US9663525, Compound I-002 | US9663525, Compound I-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329795BDBM329795(US9663525, Compound I-003 | (rac)((1R,2R,3S,4R)-4-...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329799BDBM329799(US9663525, Compound I-007 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329797BDBM329797(US9663525, Compound I-005 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329818BDBM329818(US9663525, Compound I-026 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329819BDBM329819(US9663525, Compound I-027 | (rac)-((1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329816BDBM329816(US9663525, Compound I-024 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329822BDBM329822(US9663525, Compound I-030 | (rac)-((1R,2R,3S,4R)-4...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetUbiquitin-like modifier-activating enzyme 1(Human)
Millennium Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 329823BDBM329823(US9663525, Compound I-031 | (rac)-[(1R,2R,3S,4R)-2...)
Affinity DataIC50: 10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: